Overview
CRISIL Limited has approved a $30 million credit facility for its wholly owned subsidiary, Crisil Irevna UK Limited. The move, formalized on September 9, 2025, is aimed at supporting the subsidiary’s general business needs and strategic initiatives.
The facility can be drawn in multiple tranches, carries no security requirement, and is structured as an arm’s length related party transaction.
Credit Facility Details
- Amount: Up to USD 30 million
- Beneficiary: Crisil Irevna UK Limited (wholly owned subsidiary)
- Structure: Flexible, usable in one or more tranches
- Purpose: To meet general business needs and fund strategic initiatives
- Loan Status: No outstanding loans as of now
- Security: None provided
- Special Rights: No director appointment, share subscription, or other rights attached
Regulatory Compliance
The transaction was disclosed under Regulation 30 of SEBI (LODR) Regulations, 2015. CRISIL confirmed that the agreement adheres to transparency and governance requirements, given its nature as a related-party transaction.
Strategic Importance
This initiative highlights CRISIL’s intent to strengthen its global operations, with a particular focus on the UK market. By extending financial flexibility to Crisil Irevna UK Limited, the parent company aims to:
- Support expansion of international operations
- Enhance operational capacity for growth
- Back the subsidiary’s strategic initiatives in Europe
CRISIL emphasized that this credit facility reflects its confidence in UK operations and aligns with its long-term strategy of deepening its global presence.
Summary
- CRISIL Limited has approved a $30 million credit line for its UK subsidiary, Crisil Irevna UK Limited.
- The facility, signed on September 9, 2025, is for general business and strategic growth needs.
- It is structured as an arm’s length related party transaction, with no security or special rights.
- The move demonstrates CRISIL’s commitment to strengthening international operations, especially in the UK market.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.